4sight Health September 14, 2023
David Burda

How will CMS’ all-payer, global-budget demonstration project impact the push for more healthcare value and innovation? We talked about it on the new episode of the 4sight Health Roundup podcast.
  • David W. Johnson is CEO of 4sight Health.
  • Julie Vaughan Murchinson is Partner of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Equity/SDOH, Govt Agencies, Healthcare System, Insurance, Payer, Payment Models, Population Health Mgmt, Provider, States, Value Based
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year
CMS says record 24.2 million enrolled in Marketplace coverage for 2025

Share This Article